Clinical TrialsSearch results
Number of results: 316
Other
- Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancer
- colorectal cancer
- Mlnlstry of health, Labour and Welfare
- 2008-07-07
Recruiting
- Rare sugar in the patient with autism
- Impairments in social and language skills.Obesty
- Monden Yukifumi
- 2019-03-22
Recruiting
- Phase I/II Study of Gene Therapy for Sporadic ALS
- Sporadic amyotrophic lateral sclerosis (Sporadic ALS)
- Morita Mitsuya
- 2022-03-22
Recruiting
- Long-term observational study of Gene Therapy for Sporadic ALS
- Sporadic amyotrophic lateral sclerosis (Sporadic ALS)
- Morita Mitsuya
- 2023-08-09
Other
- Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I study
- unresectable, locally recurrent or remnant gastric cancer
- Multi-modality therapy for gastric cancer study group
- 2005-09-22
Recruiting
- A Feasibility Study of definitive radiotherapy with FOLFOX for Esophageal Cancer
- Esophageal cancer
- Murofushi Keiko
- 2022-07-20
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients
- hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 04 executive committee
- 2005-08-12